What Does It Take To Be A Biologics CDMO That Can Serve Today's Mammalian Clinical Manufacturing Needs?

By Abby Sorensen, Marketing Manager, Scorpius BioManufacturing

Scientist clean room cell culture-GettyImages-542712102

Launching a novel biologic therapeutic is fraught with challenges, especially navigating the complexities of clinical manufacturing. Finding a trusted CDMO partner capable of guiding emerging biotechs throughout their product’s lifecycle and accelerating time to market is crucial for maximizing the potential success of your novel therapeutic.

Scorpius BioManufacturing specializes in mammalian clinical manufacturing, crafting monoclonal antibodies, bispecifics, and recombinant proteins with meticulous precision. Our cutting-edge facility, built around the power of single-use systems, eliminates contamination risks and streamlines production, ensuring faster changeovers and greater flexibility.

But our true advantage lies in our people. Decades of industry experience flow through our veins, guiding your project with data-driven decisions and unwavering collaboration. We work hand-in-hand with you, upstream and downstream, optimizing processes, maximizing yield, and minimizing your cost of goods.

Brian O'Mara, Senior Director of Manufacturing, Sciences & Technology at Scorpius BioManufacturing, discusses Scorpius’ mammalian clinical manufacturing capabilities and how to overcome manufacturing challenges as companies attempt to scale their programs.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma